|
|
Study on the effects of Trichostatin A on behaviors and expression of brain-derived neurotrophic factor in model rats with depression |
LI Kun1 SUN Guoping2 LU Haozhong2 SUN Zhongguo2 |
1.Pharmacy Intravenous Admixture Services, Qilu Hospital of Shandong University (Qingdao), Shandong Province, Qingdao 265000, China;
2.Qingdao Mental Health Center, Shandong Province, Qingdao 266034, China |
|
|
Abstract Objective To investigate the effects of Trichostatin A on behaviors and expression of brain-derived neurotrophic factor (BDNF) in model rats with chronic unpredictable mild stress-induced depression (CUMS). Methods Forty adult male SD rats were randomly divided into normal control group, model group, Fluoxetine group and Trichostatin A group. The model of depression was established with alternative unpredictable stress combining isolated living conditions. The rat ethological changes were assessed by body weight, sucrose consumption and open field test. The protein expressions of BDNF and phosphorylated cAMP responsive element binding protein (p-CREB) were measured by Western blot. Results After modeling for 21 days, the body weight, sucrose consumption, horizontal motion and vertical motion scores in model group were significantly lower than those of normal control group (P < 0.05); however, these ethological indexes in Fluoxetine group and Trichostatin A group were obviously increased compared with those of model group (P < 0.05). The results of Western blot showed that the expression of BDNF and p-CREB in model group were significantly lower than those of normal control group (P < 0.05), while the expression of BDNF and p-CREB in Fluoxetine group and Trichostatin A group were significantly higher than those of model group (P < 0.05). Conclusion Trichostatin A can effectively improve depression-like behaviors in CUMS model rats, its anti-depressive effect may be attributed to up-regulation of the CREB-BDNF signaling pathway.
|
|
|
|
|
[1] Gautam-Jaipur S,Batra-Jaipur L,Gada-Mumbai ML,et al. Clinical practice guidelines for the management of depression [J]. Indian J Psychiatry,2017,7(4):22-26. PMID:28216784 DOI:10.4103/0019-5545.196973
[2] Fuchikami M,Yamamoto S,Morinobu S,et al. The potential use of histone deacetylase inhibitors in the treatment of depression [J]. Prog Neuropsychopharmacol Biol Psychiatry,2016,64(1):320-324. PMID:25818247 DOI:10.1016/ j.pnpbp.2015.03.010
[3] Fukada M,Hanai A,Nakayama A,et al. Loss of deacetylation activity of Hdac6 affects emotional behavior in mice [J]. PLoS One,2012,7(2):e30924. PMID:22328923 DOI:10.1371/ journal.pone.0030924
[4] Ageta-Ishihara N,Miyata T,Ohshima C,et al. Septins promote dendrite and axon development by negatively regulating microtubule stability via HDAC6-mediated deacetylation [J]. Nat Commun,2013,4(10):2532. PMID:24113571 DOI:10.1038/ncomms3532,
[5] 刘静,王含彦.脑源性神经营养因子在抑郁症中的作用及其信号通路[J].中国医药导报,2015,12(36):49-52.
[6] Jianhua F,Wei W,Xiaomei L,et al. Chronic social defeat stress leads to changes of behaviour and memory-associated proteins of young mice [J]. Behav Brain Res,2017,316:136-144. PMID:27609644 DOI:10.1016/j.bbr.2016.09.011
[7] Sen T,Sen N. Isoflurane-induced inactivation of CREB through histone deacetylase 4 is responsible for cognitive impairment in developing brain [J]. Neurobiol Dis,2016, 96:12-21. PMID:27544482 DOI:10.1016/j.nbd.2016. 08.005
[8] Yang JL,Liu X,Jiang H,et al. The effects of high-fat-diet combined with chronic unpredictable mild stress on depression-like behavior and leptin/lepRb in male rats [J]. Sci Rep,2016,6:35239. PMID:27739518 DOI:10.1038/srep35239
[9] Ignacio ZM,Reus GZ,Abelaira HM,et al. Quetiapine treatment reverses depressive-like behavior and reduces DNA methyltransferase activity induced by maternal deprivation [J]. Behav Brain Res,2016,320:225-232. PMID:27913254 DOI:10.1016/j.bbr.2016.11.044
[10] Covington HR,Maze I,Vialou V,et al. Antidepressant action of HDAC inhibition in the prefrontal cortex [J]. Neuroscience,2015,298:329-335. PMID:25907440 DOI:10. 1016/j.neuroscience.2015.04.030
[11] Lee P,Murphy B,Miller R,et al. Mechanisms and clinical significance of histone deacetylase inhibitors:epigenetic glioblastoma therapy [J]. Anticancer Res,2015,35(2):615-625. PMID:25667438
[12] Meylan EM,Halfon O,Magistretti PJ,et al. The HDAC inhibitor SAHA improves depressive-like behavior of CRTC1-deficient mice:possible relevance for treatment-resistant depression [J]. Neuropharmacology,2016,107:111-121. PMID:26970016 DOI:10.1016/j.neuropharm.2016. 03.012
[13] Lopes-Borges J,Valvassori SS,Varela RB,et al. Histone deacetylase inhibitors reverse manic-like behaviors and protect the rat brain from energetic metabolic alterations induced by ouabain [J]. Pharmacol Biochem Behav,2015, 128(25):89-95. PMID:25433326 DOI:10.1016/j.pbb.2014. 11.014
[14] Valvassori SS,Resende WR,Budni J,et al. Sodium butyrate,a histone deacetylase inhibitor,reverses behavioral and mitochondrial alterations in animal models of depression induced by early-or late-life stress [J]. Curr Neurovasc Res,2015,12(4):312-320. PMID:26216027
[15] Srivastava P,Dhuriya YK,Gupta R,et al. Protective effect of curcumin by modulating BDNF/DARPP32/CREB in arsenic-induced alterations in dopaminergic signaling in rat corpus striatum [J]. Mol Neurobiol,2016. [Epub ahead of print] PMID:27966075 DOI:10.1007/s12035-016-0288-2
[16] Motte E,Le Stunff C,Briet C,et al. Modulation of signaling through GPCR-cAMP-PKA pathways by PDE4 depends on stimulus intensity:Possible implications for the pathogenesis of acrodysostosis without hormone resistance [J]. Mol Cell Endocrinol,2016,442:1-11. PMID:2790 8835 DOI:10.1016/j.mce.2016.11.026
[17] Xue W,Wang W,Gong T,et al. PKA-CREB-BDNF signaling regulated long lasting antidepressant activities of Yueju but not ketamine [J]. Sci Rep,2016,6:26331. PMID:27197752 DOI:10.1038/srep26331
[18] 李云娇.脑源性神经营养因子对神经退行性和精神类疾病潜在的治疗作用[J].中国医药导报,2015,12(23):45-49.
[19] Liu Z,Qi Y,Cheng Z,et al. The effects of ginsenoside Rg1 on chronic stress induced depression-like behaviors,BDNF expression and the phosphorylation of PKA and CREB in rats [J]. Neuroscience,2016,322:358-369. PMID:26926964 DOI:10.1016/j.neuroscience.2016.02.050
[20] Martinotti G,Pettorruso M,De Berardis D,et al. Agomelatine increases BDNF serum levels in depressed patients in correlation with the improvement of depressive symptoms [J]. Int J Neuropsychopharmacol,2016,19(5):pyw003. PMID:26775293 DOI:10.1093/ijnp/pyw003
[21] Scaini G,Comim CM,Oliveira GM,et al. Chronic administration of branched-chain amino acids impairs spatial memory and increases brain-derived neurotrophic factor in a rat model [J]. J Inherit Metab Dis,2013,36(5):721-730. PMID:23109061 DOI:10.1007/s10545-012-9549-z
[22] Chourbaji S,Hellweg R,Brandis D,et al. Mice with reduced brain-derived neurotrophic factor expression show decreased choline acetyltransferase activity,but regular brain monoamine levels and unaltered emotional behavior [J]. Brain Res Mol Brain Res,2004,121(1/2):28-36. PMID:14969734 DOI:10.1016/j.molbrainres.2003.11.002 |
|
|
|